Submissions
Submission Preparation Checklist
- The manuscript is original and is not under consideration by another journal.
- The manuscript fits the aims and scope of QES MedPharm Journal.
- The manuscript file is prepared according to the Instructions for Authors.
- The title page includes complete author names, affiliations, ORCID IDs where available, and corresponding author details.
- The abstract and keywords are included.
- All tables and figures are cited in the text and uploaded in appropriate format.
- References are complete, accurate, and formatted consistently.
- Ethical approval details are provided for human, animal, clinical, or laboratory studies where required.
- Informed consent has been obtained where identifiable human data, images, or case details are included.
- Animal studies include animal ethics approval and follow appropriate welfare and reporting standards, including ARRIVE where applicable.
- A conflict of interest statement is included.
- A funding statement is included.
- A data availability statement is included.
- Any use of artificial intelligence tools has been disclosed.
- All authors have approved the final manuscript and agree with its submission.
- Permission has been obtained for any copyrighted material reproduced from other sources.
Original Research Articles
Section default policy
Review Articles
<p>Review Articles provide comprehensive, balanced, and evidence-based summaries of current knowledge within the journal’s scope. Reviews may address medical, pharmaceutical, pharmacological, toxicological, preclinical, translational, or multidisciplinary biomedical topics.</p>
<p>Review articles should present a clear rationale, organized structure, critical analysis of the literature, and relevant conclusions. Narrative reviews must be scholarly and well referenced. Systematic reviews and meta-analyses should be submitted under the dedicated section for systematic reviews and meta-analyses.</p>
Systematic Reviews and Meta-Analyses
<p>This section publishes systematic reviews and meta-analyses that address clearly defined biomedical, clinical, pharmaceutical, pharmacological, toxicological, preclinical, or translational research questions.</p>
<p>Submissions should follow PRISMA reporting guidelines where applicable and must include a transparent search strategy, eligibility criteria, study selection process, quality/risk-of-bias assessment, and appropriate synthesis of findings. Protocol registration is encouraged where relevant.</p>
Short Communications
<p>Short Communications present brief but scientifically meaningful findings that fall within the scope of QES MedPharm Journal. This section is suitable for preliminary research findings, focused experimental observations, methodological updates, or concise reports of biomedical relevance.</p>
<p>Submissions should be clearly written, methodologically sound, and supported by appropriate data. Short Communications are subject to editorial screening and peer review.</p>
Case Reports and Case Series
<p>Case Reports and Case Series describe clinically relevant observations, unusual presentations, diagnostic challenges, therapeutic responses, adverse drug reactions, or findings of clear biomedical, pharmacological, or translational significance.</p>
<p>Submissions must include appropriate patient consent, ethical compliance where required, and a clear explanation of the scientific or clinical relevance of the report. Authors are encouraged to follow CARE reporting guidelines.</p>
Copyright Notice
Authors retain copyright of their published work and grant QES MedPharm Journal the right of first publication. Published articles are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0), unless otherwise stated on the article page. This license permits use, distribution, and reproduction in any medium, provided the original work is properly cited.
By submitting a manuscript, authors confirm that the work is original, that they have the right to submit it for publication, and that any third-party material included in the manuscript has appropriate permission or is properly cited according to applicable copyright requirements.
Privacy Statement
<p><strong>Privacy Statement</strong></p>
<p>
QES MedPharm Journal respects the privacy of authors, reviewers, editors, readers, and all users of this journal website. The names, email addresses, affiliations, ORCID iDs, contact details, manuscript information, review records, and other personal information entered into this journal site will be used only for the stated purposes of journal management, manuscript submission, peer review, editorial communication, publication, indexing, archiving, and scholarly record maintenance.
</p>
<p>
Personal information will not be sold, shared, or made available to any third party for commercial or unrelated purposes. Information may be used by authorized journal staff, editors, reviewers, technical administrators, indexing services, archiving services, DOI registration agencies, and publishing service providers only when necessary for legitimate journal operations.
</p>
<p>
Authors are responsible for ensuring that any personal information included in submitted manuscripts, supplementary files, acknowledgements, patient information, images, or datasets has been collected and disclosed in accordance with applicable ethical, legal, institutional, and consent requirements.
</p>
<p>
Reviewer identities and peer-review records will be treated confidentially according to the journal’s peer-review policy. Editorial and administrative records may be retained as part of the journal’s scholarly publishing record, quality assurance procedures, ethical oversight, and audit trail.
</p>
<p>
Users may contact the editorial office if they wish to update their account information, request correction of inaccurate personal details, or ask questions about the use of their information on the journal website. Some information related to published articles, editorial history, metadata, indexing, archiving, and scholarly record preservation may need to be retained permanently to maintain the integrity of the published record.
</p>
<p>
By registering with the journal website, submitting a manuscript, participating in peer review, or using the journal platform, users acknowledge that their information may be processed for the purposes described above.
</p>
